Accuray Reports Q4 Rev. $127.5mln, Up 3% YoY, FY26 Guidance Issued

• Accuray reports Q4 net revenue of $127.5mln, down 5% YoY. • Q4 net income at $1.1mln, compared to $3.4mln in the prior year. • Adjusted EBITDA at $9.4mln, down from $10.1mln YoY. • Order book-to-bill at 1.2. • FY25 net revenue at $458.5mln, up 3% YoY. • FY25 net loss at $1.6mln, compared to $15.5mln in the prior year. • Adjusted EBITDA at $31.6mln, up from $26.5mln YoY.

Accuray Incorporated (NASDAQ: ARAY) has released its Q4 earnings report, revealing a mixed performance with a slight decline in quarterly revenue but an overall annual revenue increase. The company, which specializes in radiation therapy solutions, reported a net revenue of $127.5 million for the fourth quarter, a 5% decrease from the previous year. Net income for the quarter stood at $1.1 million, down from $3.4 million in the prior year. Adjusted EBITDA for the quarter was $9.4 million, slightly lower than the previous year’s $10.1 million.

However, the fiscal year 2025 results showed a 3% increase in net revenue to $458.5 million, with a reduced net loss of $1.6 million compared to $15.5 million the previous year. The adjusted EBITDA for the year improved significantly to $28.3 million from $19.7 million.

Accuray's management highlighted the company’s resilience in navigating macroeconomic challenges and its strategic focus on innovation and service growth. The successful debt refinancing is expected to support the company’s long-term objectives, and the introduction of fiscal year 2026 guidance indicates a positive outlook with anticipated revenue growth and improved adjusted EBITDA.

Looking ahead, Accuray is projecting fiscal year 2026 net revenue between $471 million and $485 million, with adjusted EBITDA expected to range from $31 million to $35 million. The company remains committed to advancing its core strategies and expanding its global business, despite potential market and economic uncertainties.

The order book-to-bill ratio for the quarter was 1.2, indicating a healthy order backlog. The company's service revenue grew by 4% year over year, reaching $221 million for the full year, while product revenue declined by 11% year over year, reaching $238 million.

Accuray's debt refinancing, which involved exchanging approximately $82 million of notes for approximately 8.9 million shares plus $68.6 million cash and entering a $190 million senior secured credit agreement with TCW, has positioned the company well for future growth.

References:
[1] https://www.tipranks.com/news/company-announcements/accuray-incorporated-reports-mixed-fiscal-2025-results
[2] https://finance.yahoo.com/news/accuray-fiscal-q4-earnings-snapshot-203312740.html
[3] https://www.aol.com/accuray-aray-q4-2025-earnings-213853095.html